These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2687142

  • 41. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [Abstract] [Full Text] [Related]

  • 42. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K, Recker DP, Verburg KM.
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [Abstract] [Full Text] [Related]

  • 43. [Effectiveness and safety of 150 mg vs 300 mg ranitidine twice a day in duodenal ulcer].
    Schraier M, Jorge A, Pereyra JC, Carri J, Padua-Videla M, Hoffenberg P, Villalobos J, Orillac J, Waserstein M, Mendoza S.
    Acta Gastroenterol Latinoam; 1993 Oct; 23(1):13-7. PubMed ID: 8237259
    [Abstract] [Full Text] [Related]

  • 44. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 45. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 46. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
    Müller P, Simon B.
    Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
    [Abstract] [Full Text] [Related]

  • 47. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.
    Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC.
    Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357
    [Abstract] [Full Text] [Related]

  • 48. [Value of pepsinogen I in serum as a screening method for early detection of gastroduodenal lesions and follow-up in therapy with non-steroidal antirheumatic drugs].
    Kullich W, Pöllmann G, Zmerekar C, Klein G.
    Z Rheumatol; 1991 Sep; 50(1):39-45. PubMed ID: 2058321
    [Abstract] [Full Text] [Related]

  • 49. [Ranitidine VUFB in the treatment of peptic ulcer].
    Steinigerová J, Kratochvíl J.
    Vnitr Lek; 1991 Feb; 37(2):135-40. PubMed ID: 2021072
    [Abstract] [Full Text] [Related]

  • 50. [Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs].
    Müller P, Dammann HG, Langer M, Leucht U, Simon B.
    Z Gastroenterol; 1989 Feb; 27(2):83-6. PubMed ID: 2658392
    [Abstract] [Full Text] [Related]

  • 51. Ranitidine in NSAID ulcers.
    Mani V.
    Natl Med J India; 1992 Feb; 5(2):69. PubMed ID: 1304267
    [No Abstract] [Full Text] [Related]

  • 52. Acid suppression as treatment for NSAID-related peptic ulcers.
    Howden CW, Holt S.
    Am J Gastroenterol; 1991 Dec; 86(12):1720-2. PubMed ID: 1962615
    [No Abstract] [Full Text] [Related]

  • 53. Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients.
    Simon B, Müller P.
    Scand J Gastroenterol Suppl; 1994 Dec; 206():25-8. PubMed ID: 7863248
    [Abstract] [Full Text] [Related]

  • 54. [Comparison of mid- and high dosage methylprednisolone pulse therapy in chronic polyarthritis].
    Schlumpf U, Hofmann P.
    Z Rheumatol; 1990 Dec; 49(3):160-4. PubMed ID: 2378175
    [Abstract] [Full Text] [Related]

  • 55. [Endoscopic study on the gastric tolerance of antalgic-antirheumatic substances:parsalmide].
    Mirelli E, Fichera G, Boidi G.
    Minerva Med; 1976 Oct 31; 67(52):3361-70. PubMed ID: 1086990
    [Abstract] [Full Text] [Related]

  • 56. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs.
    Swift GL, Heneghan M, Williams GT, Williams BD, O'Sullivan MM, Rhodes J.
    Digestion; 1989 Oct 31; 44(2):86-94. PubMed ID: 2693162
    [Abstract] [Full Text] [Related]

  • 57. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
    Kullich W, Klein G.
    Wien Med Wochenschr; 1991 Oct 31; 141(15):331-5. PubMed ID: 1949833
    [Abstract] [Full Text] [Related]

  • 58. Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking nonsteroidal anti-inflammatory drugs. A pilot study.
    Shepherd HA, Fine D, Hillier K, Jewell R, Cox N.
    Am J Med; 1989 Jun 09; 86(6A):49-54. PubMed ID: 2735335
    [Abstract] [Full Text] [Related]

  • 59. Non-steroidal drug-induced peptic ulceration can we really protect the stomach?
    Sturrock RD.
    Br J Rheumatol; 1992 Jul 09; 31(7):435-6. PubMed ID: 1628163
    [No Abstract] [Full Text] [Related]

  • 60. Tenoxicam-induced gastropathy in the rat: a comparison with piroxicam and diclofenac sodium, and the inhibitory effects of ranitidine and sucralfate.
    al-Ghamdi MS, Dissanayake AS, Cader ZA, Jain S.
    J Int Med Res; 1991 Jul 09; 19(3):242-8. PubMed ID: 1936514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.